Three Scientists Awarded 2026 Nobel Prize in Medicine for Optogenetics Breakthrough

The 2026 Nobel Prize in Physiology or Medicine has been awarded to three researchers whose work revolutionized neuroscience by making it possible to control nerve cells with light. American scientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel received the honour on Monday for what the Nobel Assembly described as the discovery of a molecular switch for nerve cells.

The announcement was made by the Nobel Assembly at Sweden's Karolinska Institute medical university, recognizing decades of research that culminated in the field now known as optogenetics. The three laureates will share a prize sum of 12 million Swedish crowns, equivalent to approximately 1.2 million US dollars.

Optogenetics is a technique that allows scientists to control nerve signals using light, enabling researchers to understand precisely how specific cell types contribute to behaviours such as learning, fear, addiction and movement. The method works by introducing light-sensitive proteins into neurons, which can then be activated or deactivated with pulses of light.

"The Nobel Assembly said optogenetics has fundamentally altered our understanding of the brain, with every day bringing new discoveries that help solve one of humanity's great mysteries: how our incredible brain works."

Thomas Perlmann, secretary-general of the Nobel Assembly at Karolinska Institute, explained the significance of the technique in practical terms. He noted that optogenetics makes it possible to switch on or off the activity of individual nerve cells in a living brain, a capability that was previously unimaginable. Perlmann added that the method is now being used in laboratories around the world to reveal the brain's mysteries.

Per Svenningsson, who chairs the Nobel committee, emphasized the transformative nature of the discovery. In a statement, Svenningsson said optogenetics provides opportunities for mapping the brain in a way that scientists could once only dream of, highlighting how the technique has opened entirely new avenues of neurological research.

The practical applications of optogenetics extend beyond basic brain mapping. Researchers are hopeful that the technique could lead to improvements in cochlear implants, potentially allowing for more precise stimulation of the auditory nerve than what current electrical devices can achieve. This could significantly benefit individuals with hearing loss who rely on such implants.

Karl Deisseroth, 54, is a professor at Stanford University in the United States and has been a leading figure in the development of optogenetics. Peter Hegemann, 71, serves as a neuroscience professor at Humboldt University of Berlin, while Georg Nagel, 73, is a biophysics professor at the University of Wurzburg. Their complementary expertise across neuroscience, biophysics and molecular biology proved essential in developing the revolutionary technique.

The three scientists were reportedly delighted to receive the honour together. Perlmann recounted their reaction, saying all three expressed that they thought it was absolutely wonderful to receive the prize alongside the other two, whom they consider friends. He added that they viewed it as a great honour to be recognized jointly for their contributions.

The medicine prize is traditionally the first of the Nobel Prizes to be announced each October. The winners of the prizes in physics, chemistry, literature, peace and economics will be revealed throughout the coming week, continuing the annual tradition that captures global attention.

Among the upcoming announcements, perhaps the most keenly anticipated is the peace prize, which is due on Friday. Unlike the other Nobel Prizes that are awarded in Stockholm, the peace prize is the only one presented in Oslo, Norway. Experts have suggested that the jury could choose a laureate this year who enjoys broad consensus, following last year's controversial selection of Venezuelan opposition leader Maria Corina Machado.

The Nobel Prizes were established through the will of Alfred Nobel, the Swedish inventor of dynamite, who died in 1896. Laureates receive their awards on December 10 each year, the anniversary of Nobel's death. The ceremonies are attended by Sweden's and Norway's royal families, with banquets held in their honour.

Optogenetics has emerged as one of the most important tools in modern neuroscience since its development. The technique has allowed researchers to move beyond simply observing brain activity to actively controlling it, providing unprecedented insights into how neural circuits function and how they malfunction in various neurological and psychiatric conditions.

The recognition of Deisseroth, Hegemann and Nagel represents a significant moment for the field of neuroscience, which has increasingly relied on optogenetic methods to advance understanding of brain function. Their work has laid the foundation for countless studies that continue to explore the complexities of the human brain.

The 2026 Nobel Prize in Physiology or Medicine serves as a reminder of how fundamental scientific discoveries can transform entire fields of research and open doors to applications that were once considered science fiction. The work honoured this year exemplifies the power of international collaboration in advancing human knowledge.